Combined diffusion-weighted MRI and diffusion-weighted MR spectroscopy for interrogating the glioma tumour microenvironment: a preliminary study
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background and purpose
Gliomas are characterised by a complex tumour microenvironment (TME) that contributes to treatment resistance and tumour heterogeneity. Therefore, the non-invasive interrogation of both the intracellular and extracellular compartments of gliomas remains a key unmet need. We investigated the feasibility and complementarity of combining diffusion-weighted MRI (DW-MRI) with biophysical modelling Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours (VERDICT) and diffusion-weighted MR spectroscopy (DW-MRS) for simultaneous characterisation of glioma tumour cells and the glioma TME.
Methods
14 patients with newly diagnosed glioma (WHO grades 2–4: 4 IDH-wildtype and 10 IDH-mutant) underwent DW-MRI at 3 T; DW-MRS was additionally acquired in 10 patients. Tumours were automatically segmented into enhancing, non-enhancing, and oedema regions using a validated pipeline. VERDICT models were fitted to multi-shell DW-MRI data to estimate intracellular volume fraction (f IC ), cell radius, extracellular diffusivities (D and D), and free-water fraction (f FW ). Single voxel DW-MRS (20×20×20 mm³) provided metabolite-specific apparent diffusion coefficients (ADCs) for total N-acetylaspartate (tNAA), Creatine (tCr), and choline (tCho). T-tests assessed DW-MRI and descriptive statistics assessed DW-MRS parameters in tumour regions compared to normal appearing white matter (NAWM) and IDH mutation status. Pearson’s correlations assessed associations between DW-MRS metabolite ADCs and DW-MRI parameters.
Results
VERDICT-MRI distinguished high grade IDH-wildtype from lower grade IDH-mutant gliomas, with significantly higher f IC and lower D and D in enhancing and non-enhancing regions of IDH-wildtype lesions. DW-MRS demonstrated a trend towards reduction in tNAA ADC in tumour versus contralateral NAWM, consistent with neuronal loss, and a trend towards increased tCho ADC, suggesting glial activation. A descriptive trend towards decreased tNAA ADC in IDH-wildtype tumours was observed. Significant positive correlations were identified between tumoral tCho ADC and VERDICT parameters f EES , D and negative correlations for ADC and f FW , in non-enhancing tumour regions.
Conclusion
This proof-of-concept study demonstrates the feasibility of combining multi b-value DW-MRI and DW-MRS within a clinically feasible protocol to simultaneously probe the extracellular and intracellular compartments of the glioma TME. VERDICT captured cell-level and extracellular matrix differences in IDH mutation status, while DW-MRS provided metabolite-specific indices of neuronal and glial compartment integrity. The correlation between tCho ADC and VERDICT metrics in infiltrative tumour regions supports the complementarity of these modalities. With this combined approach, it is possible to simultaneously characterise the tumour compartment and the tumour microenvironment in gliomas.
